Matt Sonnier
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
Papers in
-
- Pharmacogenetics and Drug Metabolism 7
- Cannabis and Cannabinoid Research 1
-
- Carcinogens and Genotoxicity Assessment 4
- Co-authors
- Thierry Cresteil (4 shared papers)Bernard Monsarrat (1 shared paper)Isabelle Royer (1 shared paper)Michel Wright (1 shared paper)Jean‐Marc Tréluyer (3 shared papers)Gérard Pons (3 shared papers)Elisabeth Rey (2 shared papers)Henri Hoellinger (6 shared papers)
- Journals
- Drug and Chemical Toxicology (2 papers)Clinical Toxicology (1 paper)Toxicology and Applied Pharmacology (1 paper)British Journal of Clinical Pharmacology (1 paper)Communications Biology (1 paper)
- Partner nations
- FranceUnited Kingdom
In The Last Decade
Matt Sonnier
14 papers receiving 483 citations
Peers
Comparison fields: 5 of 103
- Pharmacology 108
- Oncology 138
- Clinical Biochemistry 16
- Pharmaceutical Science 14
- Cancer Research 31
Countries citing papers authored by Matt Sonnier
This map shows the geographic impact of Matt Sonnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Sonnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Sonnier more than expected).
Fields of papers citing papers by Matt Sonnier
This network shows the impact of papers produced by Matt Sonnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Sonnier. The network helps show where Matt Sonnier may publish in the future.
Co-authors
The 22 scholars most cited alongside Matt Sonnier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 155 | |
| 2 | Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs. | 1996 | 118 |
| 3 | Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. | 1993 | 61 |
| 4 | 2001 | 38 | |
| 5 | 2003 | 38 | |
| 6 | 1987 | 30 | |
| 7 | 1989 | 17 | |
| 8 | 1978 | 14 | |
| 9 | 1985 | 11 | |
| 10 | 1989 | 9 | |
| 11 | 1983 | 8 | |
| 12 | 2008 | 4 | |
| 13 | 1980 | 3 | |
| 14 | 2003 | 2 |
About Matt Sonnier
Matt Sonnier is a scholar working on Pharmacology, Cancer Research, Oncology, Plant Science and Pharmacology, having authored 14 papers that have together received 508 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Carcinogens and Genotoxicity Assessment (4 papers), Pesticide Exposure and Toxicity (4 papers), Drug Transport and Resistance Mechanisms (3 papers), HIV/AIDS drug development and treatment (2 papers), Cell Image Analysis Techniques (1 paper), Cannabis and Cannabinoid Research (1 paper) and Contact Dermatitis and Allergies (1 paper). The work is most often cited by research in Pharmacology (108 citations), Oncology (138 citations), Clinical Biochemistry (16 citations), Pharmaceutical Science (14 citations) and Cancer Research (31 citations). Matt Sonnier has collaborated with scholars based in France and United Kingdom. Frequent co-authors include Thierry Cresteil, Bernard Monsarrat, Isabelle Royer, Michel Wright, Jean‐Marc Tréluyer, Gérard Pons, Elisabeth Rey, Henri Hoellinger, Christian Bréchot and Patrizia Paterlini-Bréchot. Their work appears in journals such as Drug and Chemical Toxicology, Clinical Toxicology, Toxicology and Applied Pharmacology, British Journal of Clinical Pharmacology and Communications Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.